GLP-1 receptor agonists
dʒiː ɛl piː wʌn rɪˈsɛptər ˈæɡənɪsts
Medications that mimic the incretin hormone, GLP-1, to control blood sugar, reduce appetite, slow down digestion and increase feelings of fullness; commonly used for type 2 diabetes and obesity
Full Explanation
GLP-1 receptor agonists are a class of medications that work by mimicking glucagon-like peptide-1 (GLP-1), a hormone naturally released in the gut after eating.
These drugs activate specific receptors (specialized protein molecules located on or within cells that receive and convert chemical signals to bring about specific physiological responses) in the pancreas, brain and digestive system to help manage blood sugar levels.
They work through multiple mechanisms: stimulating insulin release when blood sugar is high, reducing glucose production in the liver, slowing stomach emptying to feel full for longer and decreasing appetite signals in the brain.
Some medications in this class include semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound). Originally developed for type 2 diabetes, these medications are now for weight loss also. Most are given as weekly injections, though some oral versions are now available.
The most common side effects are nausea, vomiting, diarrhea and stomach discomfort. These typically occur when starting the medication or increasing doses and may reduce over time.
Most benefits reverse after stopping the medication. This means lifestyle changes including improved nutrition and regular exercise or physical activity are essential for health improvements beyond treatment.
These class of medications are prescription-only drugs and therefore advice from a licensed medical professional must be sought before usage.
Why It Matters
GLP-1 receptor agonists represent a major advancement in treating diabetes and obesity, two conditions affecting many people worldwide. According to a research published in eClinicalMedicine, "extends to a range of conditions such as cardiovascular disease, liver disease, neurodegenerative disease, and substance abuse disorders". Understanding how they work helps people make informed decisions about treatment options and set realistic expectations about benefits, side effects and the need for ongoing lifestyle changes alongside medication.
Common Misconceptions
- ✗
"These are just 'diet pills' for quick weight loss". GLP-1 receptor agonists are prescription medications for chronic disease management and not short-term diet aids. They work best when combined with lifestyle changes and require ongoing use to maintain benefits.
- ✗
"You can stop taking them once you reach your goal weight". Most people regain significant weight after stopping GLP-1 medications. They're designed for long-term use to maintain weight loss and metabolic improvements. Improved nutrition and physical activity is highly relevant to maintain long-term health.
- ✗
"All GLP-1 medications are basically the same". Different GLP-1 receptor agonists have varying potency, dosing schedules (daily vs. weekly), delivery methods (injection vs. oral) and effectiveness.